ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary

Experimental Cell Research

Volumn 317, Issue 7, 2011, Pages 910-919

  Congleton, Johanna ^a   Jiang, Hong ^a   Malavasi, Fabio ^b   Lin, Hening ^a   Yen, Andrew ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

ATRA; CD38 signaling; HL 60 differentiation

Indexed keywords

CD38 ANTIGEN; ENZYME INHIBITOR; MEMBRANE RECEPTOR; RETINOIC ACID;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOSOL; DELETION MUTANT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79952439918     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.12.003     Document Type: Article

References (57)

1. Lamkin T.J., Chin V., Varvayanis S., Smith J.L., Sramkoski R.M., Jacobberger J.W., Yen A. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels. J. Cell. Biochem. 2006, 97:1328-1338.
2. Munshi C.B., Graeff R., Lee H.C. Evidence for a causal role of CD38 expression in granulocytic differentiation of human HL-60 cells. J. Biol. Chem. 2002, 277:49453-49458.
3. Lee H.C. A unified mechanism of enzymatic synthesis of two calcium messengers: cyclic ADP-ribose and NAADP. Biol. Chem. 1999, 380:785-793.
4. Yalcintepe L., Albeniz I., Adin-Cinar S., Tiryaki D., Bermek E., Graeff R.M., Lee H.C. Nuclear CD38 in retinoic acid-induced HL-60 cells. Exp. Cell Res. 2005, 303:14-21.
5. Yen A., Freeman L., Powers V., Van Sant R., Fishbaugh J. Cell cycle dependence of calmodulin levels during HL-60 proliferation and myeloid differentiation. No changes during pre-commitment. Exp. Cell Res. 1986, 165:139-151.
6. Reiterer G., Yen A. Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer Res. 2007, 67:7765-7772.
7. Funaro A., Spagnoli G.C., Ausiello C.M., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 1990, 145:2390-2396.
8. Mallone R., Funaro A., Zubiaur M., Baj G., Ausiello C.M., Tacchetti C., Sancho J., Grossi C., Malavasi F. Signaling through CD38 induces NK cell activation. Int. Immunol. 2001, 13:397-409.
9. Munoz P., Navarro M.D., Pavon E.J., Salmeron J., Malavasi F., Sancho J., Zubiaur M. CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor. J. Biol. Chem. 2003, 278:50791-50802.
10. Funaro A., De Monte L.B., Dianzani U., Forni M., Malavasi F. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur. J. Immunol. 1993, 23:2407-2411.
11. Silvennoinen O., Nishigaki H., Kitanaka A., Kumagai M., Ito C., Malavasi F., Lin Q., Conley M.E., Campana D. CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase. J. Immunol. 1996, 156:100-107.
12. Inoue S., Kontani K., Tsujimoto N., Kanda Y., Hosoda N., Hoshino S., Hazeki O., Katada T. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines. J. Immunol. 1997, 159:5226-5232.
13. Kontani K., Kukimoto I., Nishina H., Hoshino S., Hazeki O., Kanaho Y., Katada T. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells. J. Biol. Chem. 1996, 271:1534-1537.
14. Shen M., Yen A. c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest. J. Biol. Chem. 2009, 284:25664-25677.
15. Shen M., Yen A. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells. Cancer Res. 2008, 68:8761.
16. Zubiaur M., Izquierdo M., Terhorst C., Malavasi F., Sancho J. CD38 ligation results in activation of the Raf-1/mitogen-activated protein kinase and the CD3-zeta/zeta-associated protein-70 signaling pathways in Jurkat T lymphocytes. J. Immunol. 1997, 159:193-205.
17. Zubiaur M., Guirado M., Terhorst C., Malavasi F., Sancho J. The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells. J. Biol. Chem. 1999, 274:20633-20642.
18. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 1992, 288(Pt 2):351-355.
19. Yen A., Roberson M.S., Varvayanis S., Lee A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 1998, 58:3163-3172.
20. Wang J., Yen A. A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest. J. Biol. Chem. 2008, 283:4375-4386.
21. Todisco E., Suzuki T., Srivannaboon K., Coustan-Smith E., Raimondi S.C., Behm F.G., Kitanaka A., Campana D. CD38 ligation inhibits normal and leukemic myelopoiesis. Blood 2000, 95:535-542.
22. Konopleva M., Estrov Z., Zhao S., Andreeff M., Mehta K. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells. J. Immunol. 1998, 161:4702-4708.
23. Jiang H., Congleton J., Liu Q., Merchant P., Malavasi F., Lee H.C., Hao Q., Yen A., Lin H. Mechanism-based small molecule probes for labeling CD38 on live cells. J. Am. Chem. Soc. 2009, 131:1658-1659.
24. Graeff R.M., Mehta K., Lee H.C. GDP-ribosyl cyclase activity as a measure of CD38 induction by retinoic acid in HL-60 cells. Biochem. Biophys. Res. Commun. 1994, 205:722-727.
25. Graeff R.M., Walseth T.F., Fryxell K., Branton W.D., Lee H.C. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. J. Biol. Chem. 1994, 269:30260-30267.
26. Lund F.E., Muller-Steffner H.M., Yu N., Stout C.D., Schuber F., Howard M.C. CD38 signaling in B lymphocytes is controlled by its ectodomain but occurs independently of enzymatically generated ADP-ribose or cyclic ADP-ribose. J. Immunol. 1999, 162:2693-2702.
27. Lund F.E., Muller-Steffner H., Romero-Ramirez H., Moreno-Garcia M.E., Partida-Sanchez S., Makris M., Oppenheimer N.J., Santos-Argumedo L., Schuber F. CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism. Int. Immunol. 2006, 18:1029-1042.
28. Sauve A.A., Deng H., Angeletti R.H., Schramm V.L. A covalent intermediate in CD38 is responsible for ADP-ribosylation and cyclization reactions. J. Am. Chem. Soc. 2000, 122:7856-7859.
29. Munoz P., Mittelbrunn M., de la Fuente H., Perez-Martinez M., Garcia-Perez A., Ariza-Veguillas A., Malavasi F., Zubiaur M., Sanchez-Madrid F., Sancho J. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse. Blood 2008, 111:3653-3664.
30. Trubiani O., Guarnieri S., Orciani M., Salvolini E., Di Primio R. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis. Int. J. Immunopathol. Pharmacol. 2004, 17:293-300.
31. Funaro A., Reinis M., Trubiani O., Santi S., Di Primio R., Malavasi F. CD38 functions are regulated through an internalization step. J. Immunol. 1998, 160:2238-2247.
32. Zocchi E., Franco L., Guida L., Piccini D., Tacchetti C., De Flora A. NAD+-dependent internalization of the transmembrane glycoprotein CD38 in human Namalwa B cells. FEBS Lett. 1996, 396:327-332.
33. Munshi C., Aarhus R., Graeff R., Walseth T.F., Levitt D., Lee H.C. Identification of the enzymatic active site of CD38 by site-directed mutagenesis. J. Biol. Chem. 2000, 275:21566-21571.
34. Kitanaka A., Suzuki T., Ito C., Nishigaki H., Coustan-Smith E., Tanaka T., Kubota Y., Campana D. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. J. Immunol. 1999, 162:1952-1958.
35. Lund F.E. Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. Mol. Med. 2006, 12:328-333.
36. Moreno-Garcia M.E., Partida-Sanchez S., Primack J., Sumoza-Toledo A., Muller-Steffner H., Schuber F., Oppenheimer N., Lund F.E., Santos-Argumedo L. CD38 is expressed as noncovalently associated homodimers on the surface of murine B lymphocytes. Eur. J. Biochem. 2004, 271:1025-1034.
37. Cho Y.S., Han M.K., Choi Y.B., Yun Y., Shin J., Kim U.H. Direct interaction of the CD38 cytoplasmic tail and the Lck SH2 domain. Cd38 transduces T cell activation signals through associated Lck. J. Biol. Chem. 2000, 275:1685-1690.
38. Santos S.D., Verveer P.J., Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 2007, 9:324-330.
39. Reynolds L.F., de Bettignies C., Norton T., Beeser A., Chernoff J., Tybulewicz V.L. Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1. J. Biol. Chem. 2004, 279:18239-18246.
40. Fujikawa K., Miletic A.V., Alt F.W., Faccio R., Brown T., Hoog J., Fredericks J., Nishi S., Mildiner S., Moores S.L., Brugge J., Rosen F.S., Swat W. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J. Exp. Med. 2003, 198:1595-1608.
41. Yan G.R., Xiao C.L., He G.W., Yin X.F., Chen N.P., Cao Y., He Q.Y. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics 2010, 10:976-986.
42. Kim L.C., Song L., Haura E.B. Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 2009, 6:587-595.
43. Katagiri K., Yokoyama K.K., Yamamoto T., Omura S., Irie S., Katagiri T. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J. Biol. Chem. 1996, 271:11557-11562.
44. Bertagnolo V., Brugnoli F., Mischiati C., Sereni A., Bavelloni A., Carini C., Capitani S. Vav promotes differentiation of human tumoral myeloid precursors. Exp. Cell Res. 2005, 306:56-63.
45. Notario V., Gutkind J.S., Imaizumi M., Katamine S., Robbins K.C. Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation. J. Cell Biol. 1989, 109:3129-3136.
46. Fumagalli L., Zhang H., Baruzzi A., Lowell C.A., Berton G. The Src family kinases Hck and Fgr regulate neutrophil responses to N-formyl-methionyl-leucyl-phenylalanine. J. Immunol. 2007, 178:3874-3885.
47. Yue J., Wei W., Lam C.M., Zhao Y.J., Dong M., Zhang L.R., Zhang L.H., Lee H.C. CD38/cADPR/Ca2+ pathway promotes cell proliferation and delays nerve growth factor-induced differentiation in PC12 cells. J. Biol. Chem. 2009, 284:29335-29342.
48. Paul R., Obermaier B., Van Ziffle J., Angele B., Pfister H.W., Lowell C.A., Koedel U. Myeloid Src kinases regulate phagocytosis and oxidative burst in pneumococcal meningitis by activating NADPH oxidase. J. Leukoc. Biol. 2008, 84:1141-1150.
49. Reiterer G., Bunaciu R.P., Smith J.L., Yen A. Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells. FEBS Lett. 2008, 582:2508-2514.
50. Suen P.W., Ilic D., Caveggion E., Berton G., Damsky C.H., Lowell C.A. Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages. J. Cell Sci. 1999, 112(Pt 22):4067-4078.
51. Komano Y., Nanki T., Hayashida K., Taniguchi K., Miyasaka N. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res. Ther. 2006, 8:R152.
52. Sudhakaran P.R., Radhika A., Jacob S.S. Monocyte macrophage differentiation in vitro: fibronectin-dependent upregulation of certain macrophage-specific activities. Glycoconj. J. 2007, 24:49-55.
53. Bertagnolo V., Brugnoli F., Marchisio M., Celeghini C., Carini C., Capitani S. Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. Cell. Signal. 2004, 16:423-433.
54. Bertagnolo V., Marchisio M., Brugnoli F., Bavelloni A., Boccafogli L., Colamussi M.L., Capitani S. Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells. Cell Growth Differ. 2001, 12:193-200.
55. Wang J., Yen A. A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest. J. Biol. Chem. 2008, 283:4375.
56. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 2005, 6:827-837.
57. Malavasi F., Deaglio S., Funaro A., Ferrero E., Horenstein A.L., Ortolan E., Vaisitti T., Aydin S. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 2008, 88:841-886.